U. S. Food and Drug Administration chief Scott Gottlieb announced his planned resignation on Tuesday, the Department of Health and Human Services said, and plans to step down in one month.
U. S. Food and Drug Administration chief Scott Gottlieb announced his planned resignation on Tuesday, the Department of Health and Human Services said, and plans to step down in one month.
Gottlieb won bipartisan support for his efforts to curb the use of flavored e-cigarettes by youths, speed approval times for cheap generic medicines to increase competition and bring down prescription drug prices and boost the use of cheaper versions of expensive biotech medicines, called biosimilars.
